Smart Assistans AB has been acquired by Förenade Care AB
The private shareholders of Smart Assistans AB have sold the company to Förenade Care AB for an undisclosed consideration.
Smart Assistans provides personal care services for disabled adults, in compliance with the Swedish Act concerning Support and Services for Persons with Certain Functional Impairments. The company's services include assistance in practical tasks, as well as the promotion of patient well-being through joint social activities in various forms.
Based in Sweden, Förenade Care provides care and support services for people with disabilities. The company offers health care, social care and medical care services, in addition to operating care homes in Sweden. Förenade Care is part of Danish Förenade Group, a leading privately owned service company in the Nordic region, with approximately 8,000 employees.
Oaklins' team in Sweden advised the seller in this transaction.
Talk to the deal team
Related deals
Instituto Sanitas and Chemopharma have been acquired by Laboratorios Saval
Instituto Sanitas and Chemopharma, leading pharmaceutical laboratories in Chile, have been acquired by Laboratorios Saval S.A., a prominent pharmaceutical company based in Chile with a regional presence across Latin America. The transaction strengthens Laboratorios Saval’s growth strategy and supports its expansion in the affordable medicines segment.
Learn moreRare Patient Voice has been acquired by Konovo
Rare Patient Voice has been acquired by Konovo, a technology-first healthcare intelligence company backed by Fraser Healthcare Partners.
Learn moreLindenhofgruppe has sold its majority stake in LabPoint to Affidea Switzerland
LabPoint Medical Laboratories AG has been acquired by Affidea Switzerland AG. Through the transaction, Lindenhofgruppe AG gains a strong strategic partner to support the further development of LabPoint and will remain a shareholder with a reduced stake, continuing as a key customer of the company. It lays the foundation for LabPoint’s sustainable development under a new anchor shareholder, with the aim of further strengthening and selectively expanding its position in laboratory diagnostics.
Learn more